USES OF DPP IV INHIBITORS

METHODS FOR TREATING TESTICULAR AND OVARIAN ADRENAL REST TUMORS

CDK INHIBITORS

DOSAGE REGIMENS FOR PARP7 INHIBITORS

ORAL FORMULATIONS OF LEVOSIMENDAN FOR TREATING PULMONARY HYPERTENSION WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION

MUSCLE REGENERATION

Heterocyclic Carboxylate Compounds as Glycolate Oxidase Inhibitors

SELECTIVE ELIMINATION OF SENESCENT CELLS BY FERROPTOSIS INDUCTION

HIGHLY PURIFIED EICOSAPENTAENOIC ACID, AS FREE FATTY ACID, REDUCES FECAL CALPROTECTIN LEVELS AND PREVENTS CLINICAL RELAPSE IN ULCERATIVE COLITIS PATIENTS

METHODS OF TREATMENT OF PRIMARY BILIARY CHOLANGITIS

ANTIVIRALS TARGETING PHOSPHATIDIC ACID PHOSPHATASE (PAP)

LASOFOXIFENE TREATMENT OF BREAST CANCER

TREPROSTINIL DERIVATIVES AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS

MULTI-VESICULAR LIPID NANOPARTICLE TOLEROGENIC VACCINES FOR INDUCTION OF SYSTEMIC IMMUNE TOLERANCE IN VIVO

GAMMA POLYGLUTAMATED TETRAHYDROFOLATES AND USES THEREOF

WATER-SOLUBLE CANNABINOID/RETINOID BLEND FORMULATIONS AND METHODS OF THEIR MAKING

DEVICES AND METHODS TO TREAT AND PREVENT DIVERTICULITIS

NLRP3 oligonucleotide for use in preventing and/or treating an inflammatory disease

Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation

AGONISTIC CD28 ANTIGEN BINDING MOLECULES TARGETING HER2

CD33-Binding Polypeptides and Uses Thereof

TIGIT ANTIBODIES AND USES THEREOF

COMBINATION THERAPY FOR TREATMENT OF TUMORS COMPRISING CANCER-ASSOCIATED FIBROBLASTS

METHODS FOR DETECTING OR TREATING INFLUENZA INFECTIONS

PREPARATION METHOD AND APPLICATION OF HIGH-PURITY PLANT-DERIVED RECOMBINANT HUMAN SERUM ALBUMIN

VARIABLE LYMPHOCYTE RECEPTORS THAT TARGET THE BRAIN EXTRACELLULAR MATRIX AND METHODS OF USE

PENTAPEPTIDE AND USE THEREOF

STAT DEGRADERS AND USES THEREOF

SUBSTITUTED BENZOTHIOPHENE DERIVATIVES AND METHODS OF USE THEREOF

ENPP1 Inhibitors and Methods of Modulating Immune Response

LONP1 INHIBITORS, USES AND METHODS

KRAS MODULATING COMPOUNDS

CRYSTAL FORM OF FUSED RING DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF

sGC STIMULATORS

CRYSTALLINE FORMS OF DIAZABICYCLOOCTANE DERIVATIVE AND PRODUCTION PROCESS THEREOF

PIPERIDINYLPYRIDINYLCARBONITRILE DERIVATIVES AS INHIBITORS OF GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE AND GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE LIKE PROTEIN

PIPERIDINYLPYRIDINYLCARBONITRILE DERIVATIVES AS INHIBITORS OF GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE AND GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE LIKE PROTEIN

PLPRO INHIBITORS

CRYSTALLINE FORMS OF A COMPOUND FOR TREATING OR PREVENTING GOUT OR HYPERURICEMIA

TREATMENT OF CATAPLEXY

TREATMENT OF HYPERTENSION BY RENAL VASCULAR DELIVERY OF GUANETHIDINE

Treatment of Proliferative Disorders Using Antibodies to PSMA

CARDIAC CALCIUM HANDLING MACHINERY REMODELED IN FRIEDREICH'S ATAXIA

SURFACTANTS FOR USE IN HEALTHCARE PRODUCTS

COMBINATION THERAPY WITH ARENAVIRUS PARTICLES AND IMMUNE CHECKPOINT MODULATORS OR CYTOKINES

METHODS OF TREATING INFERTILITY

USE OF SOMATOSTATIN AGONIST IN THE TREATMENT OF SSTR3 EXPRESSING TUMORS

Recombinant rhabdovirus encoding for a CD80 extracellular domain Fc-fusion protein

USE OF ALVEOLAR OR AIRWAY ORGANOIDS FOR THE TREATMENT OF LUNG DISEASES AND DISORDERS

METHODS FOR TREATING AND/OR PREVENTING LYMPHANGIOGENESIS-ASSOCIATED DISEASES BY USING GOLD NANOCLUSTERS

METHODS FOR REDUCING OR SHUTTING DOWN LACTATION IN NON-HUMAN MAMMALS AND REAGENTS THEREFOR

MicroRNA-Based Therapy Targeted Against LCP-1 Positive Cancers

NUCLEOSIDE PHOSPHORAMIDATES

METHODS FOR TREATING PULMONARY NON-TUBERCULOUS MYCOBACTERIAL INFECTIONS

PLK1 INHIBITOR IN COMBINATION WITH ANTI-ANGIOGENICS FOR TREATING METASTATIC CANCER

COMBINATION OF A TASK1/3 CHANNEL BLOCKER WITH A MUSCARINIC RECEPTOR ANTAGONIST FOR THE TREATMENT OF SLEEP APNEA

COMBINATION OF A TASK1/3 CHANNEL BLOCKER WITH A P2X3 RECEPTOR ANTAGONIST FOR THE TREATMENT OF SLEEP APNEA

USE OF CO-ENZYME ANTAGONISTS TO SLOW METABOLISM

COMPOSITIONS AND METHODS FOR ACTIVATING SIGNALING THROUGH THE CB1 CANNABINOID RECEPTOR FOR TREATING AND PREVENTING DISEASES AND DISORDERS CHARACTERIZED BY ABNORMAL CELLULAR ACCUMULATION OF SPHINGOLIPIDS SUCH AS SPHINGOMYELIN

Compositions And Methods Targeting G12 Signaling For Bronchodilator Therapy

COMPOSITIONS COMPRISING 4-({(4-CYCLOPROPYLISOQUINOLIN-3-YL)[4-(TRIFLUOROMETHOXY)BENZYL]AMINO}SULFONYL)BENZOIC ACID AND METHODS OF USE THEREOF

COMBINATION OF AN A2-ADRENOCEPTOR SUBTYPE C (ALPHA-2C) ANTAGONIST WITH A NOREPINEPHRINE REUPTAKE INHIBITOR FOR THE TREATMENT OF SLEEP APNEA

COMPOSITIONS AND METHODS FOR TREATING INDUCED DISORDERS FOLLOWING NON-HEMORRHAGIC CLOSED HEAD INJURY

TREATING A DISEASE USING A PHARMACEUTICALLY ACTIVE INGREDIENT PRESENT IN A PSEUDO-TERNARY PHASE SYSTEM

METHODS FOR ADDRESSING INJECTION SITE REACTIONS ASSOCIATED WITH THE ADMINISTRATION OF BEVEMIPRETIDE

COMPOSITIONS, METHODS AND USES OF MESSENGER RNA

FORMULATIONS AND DOSES OF PEGYLATED URICASE

BIOMARKERS AND METHODS OF TREATING PD-1 AND PD-L1 RELATED CONDITIONS

Use of PD-L1 Low Expression Status to Select Subjects for Cancer Immunotherapy

COMPOSITIONS AND METHODS FOR DIAGNOSIS, TREATMENT OF AND PREVENTION OF KIDNEY DISEASE

METHODS AND COMPOSITIONS RELATED TO RNA-TARGETED RHO SMALL GTPase RND3/RhoE THERAPY

TREATMENT OF NEUROLOGICAL DISEASES USING MODULATORS OF UNC13A GENE TRANSCRIPTS

PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF

ANTIBODIES AND USES THEREOF

Anti-Abcb1 Antibodies

EPHA2 ANTIBODIES

Methods for the treatment of thyroid eye disease

ASGR INHIBITORS

METHODS FOR TREATING BULLOUS PEMPHIGOID USING FCRN ANTAGONISTS

TARGETED REGULATION OF PLATELET AND MEGAKARYOCYTE ACTIVATION BY HETERORECEPTOR CO-CLUSTERING

Anti-CD112R Compositions and Methods

LAG-3 COMBINATION THERAPY FOR THE TREATMENT OF CANCER

MONOVALENT INTERLEUKIN 12 (IL-12) HETERODIMERIC FC PROTEINS

POLYOMAVIRUS NEUTRALIZING ANTIBODIES

POLYPEPTIDE MODULATORS

INSULIN RECEPTOR PARTIAL AGONISTS

VSV/NDV HYBRID VIRUSES FOR ONCOLYTIC THERAPY OF CANCER

PEPTIDES AND METHODS FOR USE IN TREATING PAIN

NEUTRAL GLYCOSYLATED AMIDES AND DIANIONIC GLUCURONIDATED ACIDS AS STABILIZERS FOR BIOLOGICAL MOLECULES

TEBIPENEM PIVOXIL CRYSTALLINE FORMS, COMPOSITIONS INCLUDING THE SAME, METHODS OF MANUFACTURE, AND METHODS OF USE

MODULATORS OF MYOCYTE LIPID ACCUMULATION AND INSULIN RESISTANCE AND METHODS OF USE THEREOF

NOVEL OXADIAZOLE DERIVATIVE AND USE THEREOF

SMALL MOLECULE INHIBITORS OF PR3 AND HNE AND USES THEREOF

METHOD OF TREATMENT AND SELECTION OF PATIENTS BENEFITING FROM AGOMELATINE BASED ON EEG MEASUREMENTS

BOTTLEBRUSH CONJUGATES FOR USE AS OLIGONUCLEOTIDE ENHANCERS

Abuse-Deterrent Pharmaceutical Composition with Aversion Properties

USE OF THE NEGR1 PROTEIN AND BIOLOGICALLY ACTIVE FRAGMENTS THEREOF IN THE THERAPEUTIC TREATMENT OF ALK-RELATED DISEASES

FORMULATIONS OF GUANYLATE CYCLSE C AGONISTS AND METHODS OF USE

CANCER IMMUNOTHERAPY USING VIRUS PARTICLES

SPRAY DRIED INHALABLE BIOTHERAPEUTICS FOR THE TREATMENT OF DISEASE

COMPOSITIONS AND METHODS FOR TREATING KIDNEY DISEASE AND OTHER DISEASE

METHODS AND COMPOSITIONS FOR ALTERING A TUMOR MICROBIOME

THERAPEUTIC BLOOD-ACID-SHIFTING COMPOSITIONS AND METHODS

Methods and Compositions for Treating Mucositis

COMPOSITION FOR PROMOTING THE MATURING OF THE CENTRAL NERVOUS SYSTEM

Pharmaceutical Composition and Method for Treating Seizure Disorders

METHODS FOR TREATING AND PREVENTING C. DIFFICILE INFECTION

JAK INHIBITOR WITH A VITAMIN D ANALOG FOR TREATMENT OF SKIN DISEASES

METHODS OF TREATING A RAS PROTEIN-RELATED DISEASE OR DISORDER

INHIBITORS OF MUTANT IDH1 AND IDH2

FERROCHELATASE INHIBITORS AND METHODS OF USE

COMBINATION OF A TASK1/3 CHANNEL BLOCKER WITH A NOREPINEPHRINE REUPTAKE INHIBITOR FOR THE TREATMENT OF SLEEP APNEA

VCP/p97 INHIBITOR FOR THE TREATMENT OF CANCER

COMBINATION THERAPY FOR TREATING ABNORMAL CELL GROWTH

2,3-DIHYDROBENZO [B][1, 4]DIOXIN-2-YLMETHYL)PIPERAZIN-1-YL DERIVATES FOR THE TREATMENT OF SLEEP APNEA

THIENOPYRROLE COMPOUNDS

COMBINATION OF AN A2-ADRENOCEPTOR SUBTYPE C (ALPHA-2C) ANTAGONIST WITH A NOREPINEPHRINE REUPTAKE INHIBITOR FOR THE TREATMENT OF SLEEP APNEA

AUTOPHAGY INDUCING COMPOUNDS AND USES THEREOF, IN PARTICULAR FOR A SYSTEMIC TREATMENT OF DISEASES AND CONDITIONS

USE OF AMINOPYRAZOLE COMPOUNDS

METHOD FOR REDUCING SIDE EFFECTS FROM ADMINISTRATION OF PHOSPHODIESTERASE-4 INHIBITORS

COMBINATION COMPRISING A GLUCOCORTICOID AND EDO-S101

COMPOSITIONS AND METHODS FOR TREATING PRESBYOPIA, MILD HYPEROPIA, AND IRREGULAR ASTIGMATISM

Method of treatment and selection of patients benefiting from agomelatine based on EEG measurements

SULFONAMIDE DERIVATIVES AND THEIR USE AS SOLUBLE EPOXIDE HYDROLASE INHIBITORS

Membrane Encapsulated Nanoparticles and Method of Use

Membrane Encapsulated Nanoparticles and Method of Use

COMPOSITIONS AND METHODS FOR INHIBITING HAIR GROWTH

ORAL COMPOSITIONS AND METHODS OF REDUCING ORAL MALODOR

Ocular Device and Drug Delivery System, With Case

METHODS AND SYSTEMS FOR ANALYZING AND UTILIZING CANCER TESTIS ANTIGEN BURDEN

NEURONAL METHYLATION SIGNATURES FROM CELL FREE DNA AND METHODS OF USE THEREOF

METHODS AND COMPOSITIONS FOR INHIBITING DETOXIFICATION RESPONSE

Mammalian ATG8 Proteins and ATG9A Direct Sealing of Autophagosomal Membranes

A METHOD OF TREATING ACUTE MYELOID LEUKEMIA

ANTI-TNFR2 SINGLE DOMAIN ANTIBODY, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

BISPECIFIC PD-L1xCD28 ANTIBODIES AND METHODS OF USE THEREOF

ANTI-LAG3 ANTIBODY, PHARMACEUTICAL COMPOSITION AND USE

HIGH DOSE TREATMENTS FOR ALZHEIMER'S DISEASE

METHODS FOR TREATING MYELOPROLIFERATIVE DISORDERS

FUSED IN SARCOMA (FUS) NUCLEAR TRANSLOCATION INHIBITORS FOR PREVENTING FIBROSIS

DESIGNED REPEAT DOMAINS WITH DUAL BINDING SPECIFICITY AND THEIR USE

COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS

IMIDAZOTHIAZOLE DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

TETRACYCLIC OXAZEPINE COMPOUNDS AND USES THEREOF

COMPOUNDS

COMPOUNDS, COMPOSITIONS, AND METHODS

HIV INHIBITOR COMPOUNDS

CRYSTALLINE FORM OF (R)-2-(TERT-BUTYLAMINO)-1-(5-FLUOROPYRIDIN-3-YL)-ETHAN-1-OL HEMI-TARTRATE SALT FOR THE TREATMENT OF HYPERGLYCEMIA AND DIABETES 2

C7-FLUORO SUBSTITUTED TETRACYCLINE COMPOUNDS

SODIUM THIOSULFATE-CONTAINING PHARMACEUTICAL COMPOSITIONS

DRUG COATED MEDICAL DEVICES

Polyethylene Glycol Modified Zwitterionic Fluorescent Probe and Application Thereof, and Preparation

CEA ASSAY FOR PATIENT SELECTION IN CANCER THERAPY

EXCIPIENT GRANULATIONS

EXTRACTION OF PLANT SOURCE "MEDICINAL SOUP" AND MANUAL PREPARATION OF "HERBAL MEDICINE" AND RELATED PRODUCTS

METHOD OF TREATING ARRHYTHMIA, POPULATION OF PACEMAKER CARDIOMYOCYTES, AND METHOD OF TREATING CARDIAC ARRHYTHEMIA USING POPULATION OF PACEMAKER CARDIOMYOCYTES

METHODS AND MATERIALS FOR TREATING CANCER

COMPOSITIONS AND METHODS FOR TREATMENT OF HOMOCYSTINURIA

MODIFIED CAVEOLIN-1 PEPTIDES FOR THE TREATMENT OF POST-ACUTE COVID-19

GALECTIN-1 DELIVERY FOR THERAPEUTIC CONTROL OF INTESTINAL INFLAMMATION

BIFIDOBACTERIA FOR TREATING DIABETES AND RELATED CONDITIONS

COMBINATION CANCER THERAPY

Pharmaceutical Composition Comprising Salmonella Strain and Immune Checkpoint Inhibitor as Active Ingredient for Prevention or Treatment of Cancer

METHOD FOR TREATING BURN PAIN

INTRAPERITONEAL INJECTION OF HUMAN PLACENTA STEM CELLS PROTECT THE BRAIN FROM STROKE INJURY VIA EXOSOME/MICROPARTICLE FORMATION AND ACE2 MAINTENANCE OF BRAIN PERFUSION

GENE EDITING METHODS FOR MODULATING EXPRESSION OF ID-3, AN INHIBITOR OF DNA-BINDING TRANSCRIPTION FACTORS, THEREBY AFFECTING T-CELL FUNCTION

POLYPEPTIDES TARGETING CD105+ CANCERS

METHOD OF TREATING OBESITY BY SELECTIVE TARGETING OF VISCERAL ADIPOSITY USING POLYCATION NANOMEDICINE

BICYCLIC HETEROARYL DERIVATIVES AS ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1 INHIBITORS

STERILANTS COMPOSITION, KITS AND METHODS OF USE THEREOF

COMBINATION THERAPY FOR CANCER TREATMENT

COMBINATIONS COMPRISING POSITIVE ALLOSTERIC MODULATORS OR ORTHOSTERIC AGONISTS OF METABOTROPIC GLUTAMATERGIC RECEPTOR SUBTYPE 2 AND THEIR USE

PHARMACEUTICAL COMBINATION COMPRISING ABEMACICLIB AND A PI3K AND/OR A MTOR INHIBITOR FOR THE TREATMENT OF MANTLE CELL LYMPHOMA

COMPOSITIONS AND METHODS FOR TREATING CANCER VIA PTP1B INHIBITION

METHODS AND COMPOSITIONS FOR TREATING MELANOMA

PHARMACEUTICAL COMPOSITIONS COMPRISING LEVODOPA, A DOPAMINE DECARBOXYLASE INHIBITOR AND A COMT INHIBITOR AND METHOD OF ADMINISTRATION THEREOF

COMPOSITIONS AND METHODS FOR USE OF EFLORNITHINE AND DERIVATIVES AND ANALOGS THEREOF TO TREAT CANCERS, INCLUDING GLIOMAS

METHODS AND COMPOSITIONS FOR TREATING VITILIGO

ENDOXIFEN FOR TREATMENT OF CANCERS

HEMOGLOBIN-BASED NANOPARTICLES

FUNCTIONALIZED BIOLOGICAL MEMBRANES WITH MODIFYING PROTEIN MOLECULES, AND METHODS OF MAKING AND USES THEREOF

FORMULATIONS OF ULTRAVIOLET (UV) DEGRADABLE MATERIALS AND USES THEREOF

Methods and compositions for targeted delivery by polymersomes

METHOD FOR TREATING CENTRAL NERVOUS SYSTEM DISEASES

INHALABLE OR INGESTIBLE LACTIC ACID COMPOSITIONS FOR THE TREATMENT OF CHRONIC LUNG DISEASE

THERMOSENSITIVE MODIFIED CHITIN SPONGE DRUG-LOADED IMPLANTED SUSTAINED-RELEASE SYSTEM, PREPARATION METHOD THEREFORE, AND USE THEREOF

COMPOSITIONS AND METHODS FOR DIAGNOSING AND/OR TREATING CHRONIC KIDNEY DISEASE

Detection of B Cell Antibody Responses in Patients with Haemophilia and Treatment Thereof

PERSISTER CONTROL BY LEVERAGING DORMANCY ASSOCIATED REDUCTION OF ANTIBIOTIC EFFLUX

COMPOSITIONS AND METHODS FOR THE TREATMENT OF TAU-RELATED DISORDERS

PHARMACEUTICAL COMPOSITION COMPRISING ANTI-TIGIT ANTIBODY AND ANTI-PD-1/ANTI-VEGFA BISPECIFIC ANTIBODY, AND USE THEREOF

C-TERMINAL EXTENDED P53 ACTIVATOR CROSSLINKED PEPTIDOMIMETIC MACROCYCLES AGAINST MDM2/MDMX

Ursolic acid morpholine and diethanolamine salts

CD73 INHIBITORS

BORONIC ACID DERIVATIVES AND THERAPEUTIC USES THEREOF

IMIDAZOPYRIDINE AMIDES AND RELATED COMPOUNDS FOR USE IN THE TREATMENT OF BACTERIAL INFECTIONS

IMIDAZOPYRIMIDINES AS EED INHIBITORS AND THE USE THEREOF

ANTI-APOPTOTIC PROTEIN BCL-2 INHIBITOR, PHARMACEUTICAL COMPOSITION AND USES THEREOF

NLRP3 INFLAMMASOME INHIBITORS

IMPROVED SELECTIVE JAK2 INHIBITORS AND METHODS OF USE

3-CYCLOAMINO-INDOLE COMPOUNDS AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO

COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR

PRODRUGS FOR COMPOUNDS SPECIFIC TO GRANZYME B AND USES THEREOF

SOLID PARTICLES COMPRISING DECELLULARIZED CARDIAC TISSUE EXTRACELLULAR MATRIX AND METHODS FOR MAKING AND USING THE SAME

Formulated and/or Co-Formulated Nanocarrier Compositions Containing TFGß Antagonist Prodrugs Useful in the Treatment of Cancer and Methods Thereof

USE OF A MURAMYL PEPTIDE IN THE TREATMENT OF SKELETAL GROWTH RETARDATION

DOSING REGIMENS FOR THE MOBILIZATION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS

SUBSTITUTED PHENYL BORONIC ACID CONTAINING POLYMERS AND METHODS OF USE

Ophthalmic Pharmaceutical Composition, Ophthalmic Kit, and Pharmaceutical Application Thereof

RUXOLITINIB FOR THE TREATMENT OF PRURIGO NODULARIS

PLK1 inhibitor in combination with anti-angiogenics for treating metastatic cancer

METHODS OF TREATMENT USING LOU064

THERAPEUTIC TARGETS AND AGENTS FOR THE TREATMENT OF POSTTRAUMATIC STRESS DISORDER

PRIMING OF CANCER CELLS WITH LOW DOSE NALTREXONE

METHODS FOR TREATING PRURITUS

LEVORPHANOL PRODRUGS AND PROCESSES FOR MAKING AND USING THEM

Crenolanib for Treating FLT3 Mutated Proliferative Disorders

QUINOLINE DERIVATIVES

METHODS OF TREATING MIGRAINE

METHODS OF TREATING MIGRAINE

BAX ACTIVATORS AND USES THEREOF IN CANCER THERAPY

IL-8 INIHIBITORS FOR USE IN THE TREATMENT OF SOME UROLOGICAL DISORDERS

TREATMENT OF CANCER WITH AN FGFR KINASE INHIBITOR

KDM1A INHIBITORS FOR THE TREATMENT OF DISEASE

TREATMENT OF MYOTONIC DISORDERS

METHODS AND COMPOSITIONS FOR TREATING COGNITIVE IMPAIRMENT

COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISORDERS

DERMATOLOGIC TOPICAL APPLICATIONS OF ROR GAMMA AND ROR GAMMA-T INHIBITORS FOR THE PREVENTION OF SKIN CANCER DEVELOPMENT

USES OF RHODOQUINONE FOR THE TREATMENT OF DISEASE

2-FLUORODESCHLOROKETAMINE FOR TREATMENT OF DEPRESSION, INCLUDING TREATMENT-RESISTANT DEPRESSION

PHARMACEUTICAL COMPOSITIONS

Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof

SELF-EMULSIFYING OIL-IN-WATER MICROEMULSION OR NANOEMULSION, AND EMULSIFYING COMPOSITION

FLEECE FOR ORAL PRODUCT WITH RELEASABLE COMPONENT

TOPICAL USE AND DELIVERY OF AMMONIA OXIDIZING MICROORGANISMS

DEVICE AND METHOD FOR STIMULATING AND SCRUBBING THE MEIBOMIAN GLANDS OF THE EYELID

DOUBLE STRANDED RNA TARGETING PROPROTEIN CONVERTASE SUBTILISIN KEXIN 9 (PCSK9) AND METHODS OF USE THEREOF

ANTI-CD39 ANTIBODIES, COMPOSITIONS COMPRISING ANTI-CD39 ANTIBODIES AND METHODS OF USING ANTI-CD39 ANTIBODIES

IDENTIFICATION OF PATHOGENIC IMMUNE CELL SUBSETS IN CHECKPOINT INHIBITOR-INDUCED MYOCARDITIS

TREATMENT OF CD20-POSITIVE B-CELL LYMPHOMA WITH OBINUTUZUMAB

A BISPECIFIC ANTI-PD-L1/VEGF ANTIBODY AND USES THEREOF

COMBINATION THERAPIES OF HDAC INHIBITORS AND PD-1 INHIBITORS

METHODS OF TREATMENT COMPRISING ANTIBODIES BINDING TO ALPHA7BETA1 INTEGRIN ANTIBODIES

MALE CONTRACEPTION

Compositions and Methods for the Delivery of Therapeutic Biologics for Treatment of Disease

IMMUNOGLOBULINS AND USES THEREOF

NOVEL BORONSOME FACILITATING DIAGNOSIS AND TREATMENT

CRYSTALLINE FORMS OF A PAR4 INHIBITOR

TETRAHYDROQUINAZOLINE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS

MUSCARINIC ACETYLCHOLINE M1 RECEPTOR ANTAGONISTS

GLUCOSYLCERAMIDE SYNTHASE INHIBITORS

17-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 13 INHIBITORS AND METHODS OF USE THEREOF

CRYSTALLINE PHARMACEUTICALLY ACCEPTABLE SALT AND POLYMORPHIC FORM OF THE GLUTAMINYL CYCLASE INHIBITOR VAROGLUTAMSTAT

3-(5-oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione Derivatives and Uses thereof

IRF-4 ENGINEERED T CELLS AND USES THEREOF IN TREATING CANCER

METHODS FOR TREATING LYSOSOMAL ACID LIPASE DEFICIENCY IN PATIENTS

COMPOSITIONS AND METHODS OF TREATING CANCER USING LIPID AGONISTS AND RECEPTORS THEREOF

COMBINATION USE OF NOVEL LACTOBACILLUS PLANTARUM STRAIN AND STRAIN-DERIVED POLYSACCHARIDE FOR PREVENTING OR TREATING TUMORS

COMPOSITIONS AND METHODS FOR INHIBITING SEIZURES

CHIMERIC ANTIGEN RECEPTOR-MODIFIED CELLS FOR THE TREATMENT OF CLDN6 EXPRESSING CANCER

PHOSPHATASE INHIBITORS AS NK CELLS MODULATORS FOR THE TREATMENT OF CANCER

DERIVATIZED CHITOSAN POLYMERS AND METHODS OF TREATING VASCULAR DISORDERS

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CHOROIDAL NEOVASCULARISATION

METHODS OF TARGETING RNF213 SIGNALING PATHWAY FOR TREATING DISEASES

WOUND HEALING MEDICAMENT

CELL IMPERMEABLE KINASE INHIBITORS TO TREAT SARS-COV-2 AND/OR HSV VIRAL INFECTIONS

CARDIO- AND RENOPROTECTIVE ANTIDIABETIC THERAPY

COMBINATION THERAPIES

DEUTERATED DERIVATIVES OF RUXOLITINIB

WT-IDH1 INHIBITION USING A COVALENT AND BRAIN-PENETRANT SMALL MOLECULAR INHIBITOR FOR FERROPTOSIS INDUCTION IN HIGH-GRADE GLIOMA

USE OF PIPENDOXIFENE TO TREAT SARS-COV-2 INFECTION

METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS

TOLL-LIKE RECEPTOR AGONISTS AND ANTAGONISTS AND USES THEREOF

Derivative of aspartic acid and use thereof in treatment of metabolic diseases such as hepatic fibrosis and non-alcoholic hepatitis

READY-TO-USE KETAMINE PREMIX FORMULATION

ORAL ABIRATERONE FORMULATIONS

Personal Lubricants With Wellness Additive Components

GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR-BASED CANCER TREATMENTS

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING TARGET CANCER INCLUDING BRCA-SPECIFIC siRNA AS ACTIVE INGREDIENT

ANTITUMORAL COMPOSITION

METHODS OF IMPROVING CARDIOVASCULAR FUNCTION AND TREATING CARDIOVASCULAR DISEASE USING A RECOMBINANT ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE (NPP1)

IL2RB/IL2G SYNTHETIC CYTOKINES

Antibody Targeting Axl Protein and Antigen Binding Fragment Thereof, and Preparation Method Therefor and Application Thereof

PYRIDO[2,3-D]PYRIMIDINE DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

L-LYSINE SALT OF 4-CHLORO-5-[4-(2,6-DICHLOROPHENYL)SULFONYLPIPERAZIN-1-YL]-1-BENZOFURAN-2-CARBOXYLIC ACID AND VARIOUS FORMS THEREOF

L-LYSINE SALT OF 4-CHLORO-5-[4-(2,6-DICHLOROPHENYL)SULFONYLPIPERAZIN-1-YL]-1-BENZOFURAN-2-CARBOXYLIC ACID AND VARIOUS FORMS THEREOF

ALPHA AND GAMMA-D POLYGLUTAMATED ANTIFOLATES AND USES THEREOF

COMPOSITIONS FOR SUPPLEMENTING PRODUCTS WITH THERAPEUTIC AGENTS AND METHOD OF USE THEREOF

INJECTABLE SLURRIES AND METHODS OF MANUFACTURING AND USING THE SAME

ADJUVANT TREATMENT OF HER2-POSITIVE BREAST CANCER

METHODS TO ALTER THE TUMOR MICROENVIRONMENT FOR EFFECTIVE CANCER IMMUNOTHERAPY

PHARMACEUTICAL COMPOSITION

SERUM RESPONSE FACTOR REGENERATES SENESCENT CELLS

METHODS AND COMPOSITIONS FOR TREATING MUCOSAL TISSUE DISORDERS

SYNERGISTIC HERBAL COMPOSITIONS FOR TESTOSTERONE BOOSTING

COMPOSITIONS AND METHODS FOR TREATING OVARIAN AGING, OVARIAN DISEASES AND CONDITIONS, AND SYMPTOMS THEREOF

Probiotic Delivery Systems

AMMONIA OXIDIZING MICROORGANISMS FOR THE TREATMENT OF HEADACHES

CROSSLINKED HYDROGELS WITH ENHANCED RADIOPACITY FOR MEDICAL APPLICATIONS

Formulations and Methods for Treating Symptoms of Menopause